Search

everythinglearnresearchcommunity

for

Search:↓

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

Different PCOS subgroups have similar metabolic features, but those without menstrual problems have milder issues.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Early-onset hair loss in young males is linked to a higher risk of metabolic syndrome.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Metabolic syndrome's individual issues are real and need treatment to reduce diabetes and heart disease risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

People with Parkinson's disease have higher levels of cortisone in their hair, which may indicate chronic stress hormone dysfunction.

Finasteride causes harmful organ changes in female mice.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

People with androgenic alopecia (AGA) have a higher chance of getting metabolic syndrome.

New treatments for low male hormones improved sexual function and mood but had unclear risks, especially for older men.

More research is needed on the health effects of hormone therapy for transgender and nonbinary people.

Eclipta alba extract may work as an anticancer agent and help reverse drug resistance.

Testosterone is crucial for development, growth, and various body functions in mammals.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

PCOS is a common hormonal disorder in women, marked by symptoms like hair growth and menstrual issues, and requires personalized treatment.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.